dr. beckermann on tki/immunotherapy combinations in mrcc
Published 4 years ago • 82 plays • Length 1:19Download video MP4
Download video MP3
Similar videos
-
1:20
dr. beckermann on sequencing strategies in mrcc
-
2:16
dr. amin on toxicities with immunotherapy/tki combinations in rcc
-
1:35
dr. lee on the combination of immunotherapy and tkis in mrcc
-
1:35
dr. grigg on immunotherapy/tki combinations in rcc
-
3:15
tki/i-o therapy in mrcc
-
0:59
dr. alva on tki monotherapy and combinations for rcc
-
5:15
favorable-risk rcc: frontline vegf tki/io combinations
-
1:09
dr. lee on combining tkis with immunotherapy in mrcc
-
2:09
dr. sweis on immunotherapy combinations in kidney cancer
-
4:27
vegf-tki therapy in first-line mrcc
-
0:54
dr. vaishampayan on immunotherapy in mrcc
-
3:15
a novel approach: tki/i-o combinations in rcc
-
41:21
the role of tyrosine kinase inhibitors and mtor inhibitors
-
5:01
vegf tki therapy after i/o in mrcc
-
6:56
role of tkis in intermediate or poor-risk mrcc
-
9:52
factors in selecting immunotherapy or tki inhibition
-
1:08
dr. inman on immunotherapy combinations in bladder cancer
-
4:49
frontline tki strategies in kidney cancer
-
7:55
mrcc: identifying and managing aes in tkis and io therapy